The PPARγ-SETD8 axis constitutes an epigenetic, p53-independent checkpoint on p21-mediated cellular senescence
Chieh-Tien Shih1, Yi-Feng Chang2, Yi-Tung Chen1
1Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan.
Abstract:
Cellular senescence is a permanent proliferative arrest triggered by genome instability or aberrant growth stresses, acting as a protective or even tumor-suppressive mechanism. While several key aspects of gene regulation have been known to program this cessation of cell growth, the involvement of the epigenetic regulation has just emerged but remains largely unresolved. Using a systems approach that is based on targeted gene profiling, we uncovered known and novel chromatin modifiers with putative link to the senescent state of the cells. Among these, we identified SETD8 as a new target as well as a key regulator of the cellular senescence signaling. Knockdown of SETD8 triggered senescence induction in proliferative culture, irrespectively of the p53 status of the cells; ectopic expression of this epigenetic writer alleviated the extent doxorubicin-induced cellular senescence. This repressive effect of SETD8 in senescence was mediated by directly maintaining the silencing mark H4K20me1 at the locus of the senescence switch gene p21. Further in support of this regulatory link, depletion of p21 reversed this SETD8-mediated cellular senescence. Additionally, we found that PPARγ acts upstream and regulates SETD8 expression in proliferating cells. Downregulation of PPARγ coincided with the senescence induction, while its activation inhibited the progression of this process. Viewed together, our findings delineated a new epigenetic pathway through which the PPARγ-SETD8 axis directly silences p21 expression and consequently impinges on its senescence-inducing function. This implies that SETD8 may be part of a cell proliferation checkpoint mechanism and has important implications in antitumor therapeutics.
Insights
Researchers discovered a new epigenetic pathway involving PPARγ and SETD8 that silences the p21 gene, controlling cellular senescence. This finding has implications for developing new antitumor therapies targeting cell proliferation.
Area of Science:
- Epigenetics and Cellular Biology
- Cancer Research
Background:
- Cellular senescence is a critical cell cycle arrest mechanism with tumor-suppressive roles.
- While gene regulation is known to control senescence, the role of epigenetic regulation remains unclear.
- Identifying novel epigenetic regulators is crucial for understanding senescence.
Purpose of the Study:
- To uncover novel chromatin modifiers involved in cellular senescence.
- To elucidate the role of SETD8 (SET domain-containing protein 8) in regulating senescence.
- To identify upstream regulators of SETD8 in the senescence pathway.
Main Methods:
- Systems approach using targeted gene profiling to identify chromatin modifiers.
- Gene knockdown and ectopic expression experiments to assess SETD8 function.
- Analysis of histone modifications (H4K20me1) and gene expression (p21).
- Investigation of the upstream regulator PPARγ (Peroxisome proliferator-activated receptor gamma).
Main Results:
- SETD8 was identified as a key regulator of cellular senescence.
- SETD8 knockdown induced senescence, while its overexpression alleviated doxorubicin-induced senescence.
- SETD8 maintains p21 gene silencing via H4K20me1, and p21 depletion reversed SETD8-mediated senescence.
- PPARγ acts upstream of SETD8, regulating its expression and influencing senescence progression.
Conclusions:
- A novel epigenetic pathway, the PPARγ-SETD8 axis, directly silences p21, impacting senescence.
- SETD8 functions as a cell proliferation checkpoint regulator.
- This pathway offers potential targets for antitumor therapeutics.
Related Concept Videos
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Replicative Cell Senescence
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...


